(Allergan plc)

	AGN latest price $238.7815 (-1.02%) ($236.8319 - $242.2561) on Thu. Jun. 9, 2016.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.75% (three month average)
RSI	78
Latest Price	$238.7815(-1.02%)
Stocks Behave Similarly	Similar Stock List
Weekly Trend	AGN advances 4.4% a week on average for past two weeks.
Market Behavior	Value stocks sell-off for large cap. Broad based sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(53%)    XLV(51%)    XBI(47%)    ARKG(43%)    IVE(42%)
Factors Impacting AGN price	AGN will decline at least -1.375% in a week (0% probabilities).   VIXM(-29%)    TLT(-16%)    UUP(-14%)    IPO(-5%)    SHY(-4%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.375% (StdDev 2.75%)
Hourly BBV	0 ()
Intraday Trend	-0.9%

5 Day Moving Average	$239.56(-0.32%)
10 Day Moving Average	$235.32(1.47%)
20 Day Moving Average	$227.14(5.13%)
To recent high	-17.3%
To recent low	22.7%
Market Cap	$78.726b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed